With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.
The NextGen Omics US: In-Person event includes...
Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.
Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features
Last Year's Agenda at a Glance
Day One
- Genome Editing Technologies & Techniques
- Drug Discovery & Development Applications in In Vivo Therapeutics
Day Two
- Drug Discovery & Development – Target Identification and Validation
- Non-Human Models in Diagnostics & Therapeutics
